image
Geron Corporation GERN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.41
2.17 %
$ 898 M
Market Cap
-5.22
P/E
CASH FLOW STATEMENT
-219 M OPERATING CASH FLOW
-30.33%
Growth Rates
1Year -30.33%
3Years -31.77%
5Years -37.91%
7Years -40.18%
10Years -37.63%
-106 M INVESTING CASH FLOW
41.21%
Growth Rates
1Year 41.21%
3Years -35.24%
5Years -37.24%
7Years -27.95%
10Years -3.13%
334 M FINANCING CASH FLOW
-7.64%
Growth Rates
1Year -7.64%
3Years 90.25%
5Years 76.54%
7Years 125.98%
10Years 13.02%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Geron Corporation
image
00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)(250m)(250m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -175 M
Depreciation & Amortization 1.22 M
Capital Expenditures -680 K
Stock-Based Compensation 135 K
Change in Working Capital 0
Others -45.4 M
Free Cash Flow -219 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996
OPERATING CASH FLOW
Net Income (174.6) (184.1) (141.9) (116.1) (75.6) (68.5) (27.0) (27.9) (29.5) 46 K (35.7) (38.4) (68.9) (96.9) (111.4) (70.2) (62.0) (36.7) (31.4) (33.5) (80.4) (29.9) (33.9) (42.1) (32.6) (46.4) (10.8) (9.6) (10.7)
Depreciation & Amortization 1.2 1.0 0.9 0.8 0.9 0.8 59 K 76 K 81 K 56 K 47 K 0.3 0.8 1.6 1.6 1.8 2.4 1.9 1.6 3.7 3.9 4.1 4.6 4.4 4.7 3.7 1.7 1.6 1.2
Deferred Income Tax 0 0 0 0.2 0.5 (1.3) (0.4) 0.3 0.6 2.2 2.7 1.5 3.0 9.0 15.3 7.8 (8.5) 0 (4.2) 5.3 96 K 1.4 0 0 0 0 0 0 0
Stock Based Compensation 0.1 19.4 8.0 8.1 6.9 6.1 6.4 8.1 8.2 8.4 7.7 4.4 5.3 15.2 13.7 10.6 11.5 0 4.4 (0.2) 96 K 0.1 0 0 0 0 0 0 0
Other Operating Activities (45.4) (10.1) 0.6 1.0 0.3 68 K 0.2 0.2 0.2 0.4 0.3 0.3 0.2 49 K 27.3 (0.2) 9.9 (1.5) (0.8) 42 K 52.2 84 K 2.4 17.0 15.8 29.9 0.8 1.7 100 K
Change in Working Capital 0 6.1 5.0 10.5 0.4 19.1 (0.2) (1.4) 2.1 (35.3) 34.4 (4.8) 4.4 8.7 9.1 6.9 4.7 9.7 4.0 4.1 (1.6) 47 K (4.4) (1.7) (1.5) (0.8) 0.5 (1.6) (0.5)
Cash From Operations (218.6) (167.7) (127.4) (95.6) (66.7) (43.8) (21.0) (20.6) (18.4) (24.2) 9.3 (36.7) (55.1) (62.4) (44.3) (43.4) (42.0) (26.6) (26.4) (20.6) (25.9) (24.4) (31.3) (22.4) (13.6) (13.6) (7.8) (7.9) (9.9)
INVESTING CASH FLOW
Capital Expenditures (0.7) (0.8) (0.4) (0.2) (0.4) (0.4) 16 K 0 57 K 90 K (0.1) 3 K (0.9) (0.6) (0.8) (1.4) (2.3) (3.0) (0.8) (1.6) (1.5) (0.4) (0.3) (1.1) (1.2) (2.7) (1.0) (0.7) (1.1)
Other Items (105.3) (179.5) 62.5 72.2 (104.9) 27.8 (77.7) 23.0 8.8 0.2 (77.8) 21.1 61.8 32.8 (47.6) (81.6) 7.8 19.0 17.7 14.6 (16.6) (54.1) 17.6 5.0 (30.3) (10.2) (6.6) (5.6) (8.9)
Cash From Investing Activities (106.0) (180.3) 62.1 71.9 (105.3) 27.4 (77.7) 23.0 8.8 73 K (77.9) 21.1 61.0 32.1 (48.5) (83.0) 5.5 16.0 16.9 13.0 (18.2) (54.5) 17.3 3.9 (31.5) (12.9) (7.6) (6.3) (10.0)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.5) 0 0 0 0 0 0 0 0 (3.7) 0 0 0
Total Debt Repaid 34.6 29.7 0 24.9 23.9 0 0 0 0 0 0 0 0 0 0 0 0 0 55 K (0.1) (0.2) (0.4) (0.4) (0.8) 24.0 20.7 7.4 (0.5) (1.0)
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 K 0 0 (9.1) 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 159.1 119.0 17.3 3.3 0.2 0.2 7.0 51 K 1.2 0 0 0 0 0 6 K 0 0 0 0 0 0 0 0 0 0 100 K 0 100 K 1.1
Cash From Financing Activities 334.4 362.0 87.3 48.6 168.3 19.5 93.0 1.1 1.2 2.6 98.4 6.6 0.1 0.4 104.1 51.6 (0.2) 20.7 48.7 94.4 41.1 87.2 (0.1) 7.3 67.3 18.0 27.6 5.9 19.8
CHANGE IN CASH
Net Change In Cash 9.7 13.9 22.0 24.9 (3.6) 3.1 (5.8) 3.5 (8.4) (21.5) 29.8 (9.1) 6.0 (29.9) 11.4 (74.7) (36.7) 10.1 39.2 86.8 (3.0) 8.2 (14.2) (11.2) 22.1 (8.6) 12.2 (8.3) 100 K
FREE CASH FLOW
Free Cash Flow (219.3) (168.6) (127.8) (95.8) (67.1) (44.2) (21.0) (20.6) (18.4) (24.3) 9.2 (36.7) (56.0) (63.0) (45.1) (44.8) (44.3) (29.6) (27.2) (22.3) (27.5) (24.8) (31.7) (23.5) (14.8) (16.3) (8.8) (8.6) (11.0)